SCHEMBL2771192

SCHEMBL2771192

O=CC(=O)c1ccc(Oc2ccc(Cl)cc2)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.44
RAB9A P51151 3/20 0.44
ALDH1A1 P00352 1/20 0.41
FLT1 P17948 1/20 0.41
FLT4 P35916 1/20 0.41
KDR P35968 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 1/20 0.41
CASP1 P29466 1/20 0.41
NPC1 O15118 2/20 0.40
BRAF P15056 1/20 0.40
HDAC1 Q13547 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
PNLIP P16233 2/20 0.39
XDH P47989 1/20 0.39
SLC22A12 Q96S37 1/20 0.39
MAOB P27338 2/20 0.39
MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28521601 0.81 TSHR (0.63) MAPTRAB9AALDH1A1FLT1FLT4
SCHEMBL1697502 0.81 SMN1; SMN2 (0.61) MAPTRAB9AALDH1A1SMN1; SMN2TSHR
SCHEMBL30513965 0.81 SMN1; SMN2 (0.61) MAPTRAB9AALDH1A1SMN1; SMN2TSHR
SCHEMBL4117335 0.80 MAOA (0.50) MAPTRAB9AALDH1A1FLT1FLT4
SCHEMBL29351910 0.80 MAOA (0.50) MAPTRAB9AALDH1A1FLT1FLT4
SCHEMBL29377336 0.79 TSHR (0.46) MAPTRAB9AALDH1A1FLT1FLT4
SCHEMBL22406867 0.79 TSHR (0.46) MAPTRAB9AALDH1A1FLT1FLT4
SCHEMBL20006624 0.77 ALDH1A1 (0.67) MAPTRAB9AALDH1A1FLT1FLT4
SCHEMBL2774480 0.76 ALDH1A1 (0.47) MAPTRAB9AALDH1A1FLT1FLT4
SCHEMBL29039883 0.76 KMO (0.48) RAB9AALDH1A1SMN1; SMN2NPC1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110059970-A1 4-PHENYL-1,3-THIAZOLES AND 4-PHENYL-1,3-OXAZOLES DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS IPSEN PHARMA S.A.S. (FR) 2011-03-10 US disclosed
EP-2201007-A1 CANNABINOID RECEPTOR LIGANDS IPSEN PHARMA S.A.S. (FR) 2010-06-30 EP disclosed
WO-2009071753-A1 CANNABINOID RECEPTOR LIGANDS IPSEN PHARMA S.A.S. (FR) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059970-A1 4-PHENYL-1,3-THIAZOLES AND 4-PHENYL-1,3-OXAZOLES DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS CNR1, CNR2, NPY1R MAPT 2207/4885RAB9A 3068/4885ALDH1A1 1430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.